Interlace Medical Corporation designs and develops minimally invasive devices for the gynecological surgeon to enable safe, quick and reliable removal of uterine fibroids and polyps.
Location: United States, Massachusetts, Framingham
Employees: 11-50
Total raised: $20.5M
Investors 1
| Date | Name | Website |
| 17.07.2021 | Baird Capi... | bairdcapit... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.06.2009 | Series C | $20.5M | - |
Mentions in press and media 3
| Date | Title | Description |
| 07.01.2011 | Hologic inks $125 million deal for Interlace Medical | Hologic Inc. (NSDQ:HOLX) acquired Interlace Medical Inc. and its minimally invasive fibroid treatment for $125 million, saying it hopes to have Interlace’s MyoSure system on the market early this year. The Bedford, Mass.-based women’s healt... |
| 15.06.2009 | Interlace Sews Up $20.5M Series C Round | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Framingham, MA-based Interlace Medical, which develops medical devices for gynecologists, announced today it has raised $20.5 million in Series C funding. The round was led by... |
| 23.10.2008 | Nora Pharma reels in $25M for women’s health | Nora Pharmaceuticals, developer of women’s reproductive health drugs and devices, brought in $25 million in first round financing from Burrill & Co., Prospect Venture Partners and Vivo Ventures. The San Francisco-based company is still ... |